-
1
-
-
34547816651
-
Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status
-
A.G. Glass, J.V. Lacey Jr., J.D. Carreon, and R.N. Hoover Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status J Natl Cancer Inst 99 2007 1152 1161
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 1152-1161
-
-
Glass, A.G.1
Lacey, Jr.J.V.2
Carreon, J.D.3
Hoover, R.N.4
-
2
-
-
0032795728
-
Estrogen receptor-positive proliferating cells in the normal and precancerous breast
-
B.S. Shoker, C. Jarvis, R.B. Clarke, E. Anderson, J. Hewlett, and M.P. Davies et al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast Am J Pathol 155 1999 1811 1815
-
(1999)
Am J Pathol
, vol.155
, pp. 1811-1815
-
-
Shoker, B.S.1
Jarvis, C.2
Clarke, R.B.3
Anderson, E.4
Hewlett, J.5
Davies, M.P.6
-
4
-
-
0026093508
-
Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas
-
J.M. Varley, W.J. Brammar, D.P. Lane, J.E. Swallow, C. Dolan, and R.A. Walker Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas Oncogene 6 1991 413 421
-
(1991)
Oncogene
, vol.6
, pp. 413-421
-
-
Varley, J.M.1
Brammar, W.J.2
Lane, D.P.3
Swallow, J.E.4
Dolan, C.5
Walker, R.A.6
-
5
-
-
80053039210
-
Mutations in the p53 tumor suppressor gene: Important milestones at the various steps of tumorigenesis
-
N. Rivlin, R. Brosh, M. Oren, and V. Rotter Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis Genes Cancer 2 2011 466 474
-
(2011)
Genes Cancer
, vol.2
, pp. 466-474
-
-
Rivlin, N.1
Brosh, R.2
Oren, M.3
Rotter, V.4
-
6
-
-
0037386821
-
Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer
-
E.M.J.J. Berns, J.G.M. Klijn, M.P. Look, N. Grebenchtchikov, R. Vossen, and H. Peters et al. Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer Clin Cancer Res 9 2003 1253 1258
-
(2003)
Clin Cancer Res
, vol.9
, pp. 1253-1258
-
-
Berns, E.M.J.J.1
Klijn, J.G.M.2
Look, M.P.3
Grebenchtchikov, N.4
Vossen, R.5
Peters, H.6
-
7
-
-
0029084995
-
TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc-binding domains
-
A.L. Borresen, T.I. Andersen, J.E. Eyford, R.S. Cornelis, S. Thorlacius, and A. Borg et al. TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains Genes Chromosomes Cancer 14 1995 71 75
-
(1995)
Genes Chromosomes Cancer
, vol.14
, pp. 71-75
-
-
Borresen, A.L.1
Andersen, T.I.2
Eyford, J.E.3
Cornelis, R.S.4
Thorlacius, S.5
Borg, A.6
-
8
-
-
33744532403
-
Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function
-
W. Liu, S.D. Konduri, S. Bansal, B.K. Nayak, S.A. Rajasekaran, and S.M. Karuppayil et al. Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function J Biol Chem 281 2006 9837 9840
-
(2006)
J Biol Chem
, vol.281
, pp. 9837-9840
-
-
Liu, W.1
Konduri, S.D.2
Bansal, S.3
Nayak, B.K.4
Rajasekaran, S.A.5
Karuppayil, S.M.6
-
9
-
-
33747340245
-
P53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer
-
H. Yamashita, T. Toyama, M. Nishio, Y. Ando, M. Hamaguchi, and Z. Zhang et al. p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer Breast Cancer Res 8 2006 R48
-
(2006)
Breast Cancer Res
, vol.8
, pp. 48
-
-
Yamashita, H.1
Toyama, T.2
Nishio, M.3
Ando, Y.4
Hamaguchi, M.5
Zhang, Z.6
-
10
-
-
42349097865
-
P53 loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers
-
A. Shai, H.C. Pitot, and P.F. Lambert p53 loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers Cancer Res. 68 2008 2622 2631
-
(2008)
Cancer Res.
, vol.68
, pp. 2622-2631
-
-
Shai, A.1
Pitot, H.C.2
Lambert, P.F.3
-
11
-
-
77952848351
-
Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia
-
E.S. Díaz-Cruz, and P.A. Furth Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia Cancer Res 70 2010 3965 3974
-
(2010)
Cancer Res
, vol.70
, pp. 3965-3974
-
-
Díaz-Cruz, E.S.1
Furth, P.A.2
-
12
-
-
77956992175
-
Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation
-
S.D. Konduri, R. Medisetty, W. Liu, B.A. Kaipparettu, P. Srivastava, and H. Brauch et al. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation Proc Natl Acad Sci U S A 107 2010 15081 15086
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 15081-15086
-
-
Konduri, S.D.1
Medisetty, R.2
Liu, W.3
Kaipparettu, B.A.4
Srivastava, P.5
Brauch, H.6
-
13
-
-
84868129083
-
Estrogen receptor prevents p53-dependent apoptosis in breast cancer
-
S.T. Bailey, H. Shin, T. Westerling, X.S. Liu, and M. Brown Estrogen receptor prevents p53-dependent apoptosis in breast cancer Proc Natl Acad Sci U S A 109 44 2012 18060 18065
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, Issue.44
, pp. 18060-18065
-
-
Bailey, S.T.1
Shin, H.2
Westerling, T.3
Liu, X.S.4
Brown, M.5
-
14
-
-
79951978817
-
P53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines
-
L. Fernandez-Cuesta, S. Anaganti, P. Hainaut, and M. Olivier p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines Int J Cancer 128 2011 1813 1821
-
(2011)
Int J Cancer
, vol.128
, pp. 1813-1821
-
-
Fernandez-Cuesta, L.1
Anaganti, S.2
Hainaut, P.3
Olivier, M.4
-
15
-
-
68549086989
-
DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: Role of E-cadherin
-
M. Rieber, and M. Strasberg Rieber DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin Int J Cancer 125 2009 1604 1612
-
(2009)
Int J Cancer
, vol.125
, pp. 1604-1612
-
-
Rieber, M.1
Strasberg Rieber, M.2
-
16
-
-
84871698476
-
P53 regulates epithelial-mesenchymal transition induced by transforming growth factor β
-
S. Termén, E.J. Tan, C.H. Heldin, and A. Moustakas p53 regulates epithelial-mesenchymal transition induced by transforming growth factor β J Cell Physiol 228 2013 801 813
-
(2013)
J Cell Physiol
, vol.228
, pp. 801-813
-
-
Termén, S.1
Tan, E.J.2
Heldin, C.H.3
Moustakas, A.4
-
17
-
-
50649124650
-
Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha
-
S.H. Park, L.W. Cheung, A.S. Wong, and P.C. Leung Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha Mol Endocrinol 22 2008 2085 2098
-
(2008)
Mol Endocrinol
, vol.22
, pp. 2085-2098
-
-
Park, S.H.1
Cheung, L.W.2
Wong, A.S.3
Leung, P.C.4
-
18
-
-
77956533018
-
Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions
-
B. Qiao, N.W. Johnson, and J. Gao Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions Int J Oncol 37 2010 663 668
-
(2010)
Int J Oncol
, vol.37
, pp. 663-668
-
-
Qiao, B.1
Johnson, N.W.2
Gao, J.3
-
19
-
-
33947536035
-
MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells
-
U.W. Nilsson, S. Garvin, and C. Dabrosin MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells Breast Cancer Res Treat 102 2007 253 261
-
(2007)
Breast Cancer Res Treat
, vol.102
, pp. 253-261
-
-
Nilsson, U.W.1
Garvin, S.2
Dabrosin, C.3
-
20
-
-
22644443940
-
The origin of vimentin expression in invasive breast cancer: Epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?
-
E. Korsching, J. Packeisen, C. Liedtke, D. Hungermann, P. Wulfing, and P.J. van Diest et al. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 206 2005 451 457
-
(2005)
J Pathol
, vol.206
, pp. 451-457
-
-
Korsching, E.1
Packeisen, J.2
Liedtke, C.3
Hungermann, D.4
Wulfing, P.5
Van Diest, P.J.6
-
21
-
-
0031577765
-
Loss of cytokeratin expression and formation of actin stress fibers in dedifferentiated MDCK-C7 cell lines
-
V. Pollack, K. Scheiber, W. Pfaller, and H. Schramek Loss of cytokeratin expression and formation of actin stress fibers in dedifferentiated MDCK-C7 cell lines Biochem Biophys Res Commun 241 1997 541 547
-
(1997)
Biochem Biophys Res Commun
, vol.241
, pp. 541-547
-
-
Pollack, V.1
Scheiber, K.2
Pfaller, W.3
Schramek, H.4
-
22
-
-
0032502669
-
The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton
-
R.B. Hazan, and L. Norton The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton J Biol Chem 273 1998 9078 9084
-
(1998)
J Biol Chem
, vol.273
, pp. 9078-9084
-
-
Hazan, R.B.1
Norton, L.2
-
23
-
-
0029805461
-
Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer
-
G. Schaller, I. Fuchs, W. Pritze, A. Ebert, H. Herbst, and K. Pantel et al. Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer Clin Cancer Res 2 1996 1879 1885
-
(1996)
Clin Cancer Res
, vol.2
, pp. 1879-1885
-
-
Schaller, G.1
Fuchs, I.2
Pritze, W.3
Ebert, A.4
Herbst, H.5
Pantel, K.6
-
24
-
-
1942470138
-
Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer
-
U. Woelfle, G. Sauter, S. Santjer, R. Brakenhoff, and K. Pantel Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer Clin Cancer Res 10 8 2004 2670 2674
-
(2004)
Clin Cancer Res
, vol.10
, Issue.8
, pp. 2670-2674
-
-
Woelfle, U.1
Sauter, G.2
Santjer, S.3
Brakenhoff, R.4
Pantel, K.5
-
25
-
-
22944492443
-
Transfection of keratin 18 gene in human breast cancer cells causes induction of adhesion proteins and dramatic regression of malignancy in vitro and in vivo
-
H. Bühler, and G. Schaller Transfection of keratin 18 gene in human breast cancer cells causes induction of adhesion proteins and dramatic regression of malignancy in vitro and in vivo Mol Cancer Res 3 2005 365 371
-
(2005)
Mol Cancer Res
, vol.3
, pp. 365-371
-
-
Bühler, H.1
Schaller, G.2
-
26
-
-
74549144274
-
Keratin 18 attenuates estrogen receptor alpha-mediated signaling by sequestering LRP16 in cytoplasm
-
Y. Meng, Z. Wu, X. Yin, Y. Zhao, M. Chen, and Y. Si et al. Keratin 18 attenuates estrogen receptor alpha-mediated signaling by sequestering LRP16 in cytoplasm BMC Cell Biol 10 2009 96
-
(2009)
BMC Cell Biol
, vol.10
, pp. 96
-
-
Meng, Y.1
Wu, Z.2
Yin, X.3
Zhao, Y.4
Chen, M.5
Si, Y.6
-
27
-
-
63149111430
-
Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients
-
L.M. McGlynn, T. Kirkegaard, J. Edwards, S. Tovey, D. Cameron, and C. Twelves et al. Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients Clin Cancer Res 15 2009 1487 1495
-
(2009)
Clin Cancer Res
, vol.15
, pp. 1487-1495
-
-
McGlynn, L.M.1
Kirkegaard, T.2
Edwards, J.3
Tovey, S.4
Cameron, D.5
Twelves, C.6
-
28
-
-
73549115638
-
Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways
-
S.E. Ghayad, J.A. Vendrell, S. Ben Larbi, C. Dumontet, I. Bieche, and P.A. Cohen Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways Int J Cancer 126 2010 545 562
-
(2010)
Int J Cancer
, vol.126
, pp. 545-562
-
-
Ghayad, S.E.1
Vendrell, J.A.2
Ben Larbi, S.3
Dumontet, C.4
Bieche, I.5
Cohen, P.A.6
-
29
-
-
84871105827
-
Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
-
H.G. Moon, J.K. Yi, H.S. Kim, H.Y. Lee, K.M. Lee, and M. Yi et al. Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer BMC Cancer 12 2012 585
-
(2012)
BMC Cancer
, vol.12
, pp. 585
-
-
Moon, H.G.1
Yi, J.K.2
Kim, H.S.3
Lee, H.Y.4
Lee, K.M.5
Yi, M.6
-
30
-
-
42549131382
-
Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity
-
R.S. Thomas, N. Sarwar, F. Phoenix, R.C. Coombes, and S. Ali Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity J Mol Endocrinol 40 2008 173
-
(2008)
J Mol Endocrinol
, vol.40
, pp. 173
-
-
Thomas, R.S.1
Sarwar, N.2
Phoenix, F.3
Coombes, R.C.4
Ali, S.5
-
31
-
-
77952740909
-
Inhibition of MAP kinase promotes the recruitment of corepressor SMRT by tamoxifen-bound estrogen receptor alpha and potentiates tamoxifen action in MCF-7 cells
-
W. Hong, L. Chen, J. Li, and Z. Yao Inhibition of MAP kinase promotes the recruitment of corepressor SMRT by tamoxifen-bound estrogen receptor alpha and potentiates tamoxifen action in MCF-7 cells Biochem Biophys Res Commun 396 2010 299 303
-
(2010)
Biochem Biophys Res Commun
, vol.396
, pp. 299-303
-
-
Hong, W.1
Chen, L.2
Li, J.3
Yao, Z.4
-
32
-
-
4444251799
-
Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitro
-
A. Yacoub, S.I. Han, R. Caron, D. Gilfor, S. Mooberry, and S. Grant et al. Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitro Cancer Biol Ther 2 2003 670 676
-
(2003)
Cancer Biol Ther
, vol.2
, pp. 670-676
-
-
Yacoub, A.1
Han, S.I.2
Caron, R.3
Gilfor, D.4
Mooberry, S.5
Grant, S.6
-
33
-
-
84869238813
-
Hypoxia Mn-SOD and H2O2 regulate p53 reactivation and PRIMA-1 toxicity irrespective of p53 status in human breast cancer cells
-
M. Rieber, and M. Strasberg-Rieber Hypoxia Mn-SOD and H2O2 regulate p53 reactivation and PRIMA-1 toxicity irrespective of p53 status in human breast cancer cells Biochem Pharmacol 84 2012 1563 1570
-
(2012)
Biochem Pharmacol
, vol.84
, pp. 1563-1570
-
-
Rieber, M.1
Strasberg-Rieber, M.2
-
35
-
-
0042596102
-
Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells
-
E. Toschi, R. Rota, A. Antonini, G. Melillo, and M.C. Capogrossi Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells J Invest Dermatol 114 2000 1188 1194
-
(2000)
J Invest Dermatol
, vol.114
, pp. 1188-1194
-
-
Toschi, E.1
Rota, R.2
Antonini, A.3
Melillo, G.4
Capogrossi, M.C.5
-
36
-
-
79551576468
-
Mechanisms of endocrine resistance in breast cancer
-
C.K. Osborne, and R. Schiff Mechanisms of endocrine resistance in breast cancer Annu Rev Med 62 2011 233 247
-
(2011)
Annu Rev Med
, vol.62
, pp. 233-247
-
-
Osborne, C.K.1
Schiff, R.2
-
37
-
-
64549133889
-
Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer
-
Y. Tabuchi, J. Matsuoka, M. Gunduz, T. Imada, R. Ono, and M. Ito et al. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer Int J Oncol 34 2009 313 319
-
(2009)
Int J Oncol
, vol.34
, pp. 313-319
-
-
Tabuchi, Y.1
Matsuoka, J.2
Gunduz, M.3
Imada, T.4
Ono, R.5
Ito, M.6
-
38
-
-
0034896331
-
P53-dependent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide
-
M. Strasberg Rieber, U. Zangemeister-Wittke, and M. Rieber p53-dependent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide Clin Cancer Res 7 2001 1446 1451
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1446-1451
-
-
Strasberg Rieber, M.1
Zangemeister-Wittke, U.2
Rieber, M.3
-
39
-
-
84878444751
-
17β-estradiol activates glucose uptake via GLUT4 translocation and PI3K/Akt signaling pathway in MCF-7 Cells
-
P. Garrido, J. Morán, A. Alonso, S. González, and C. González 17β-estradiol activates glucose uptake via GLUT4 translocation and PI3K/Akt signaling pathway in MCF-7 Cells Endocrinology 154 2013 1979 1989
-
(2013)
Endocrinology
, vol.154
, pp. 1979-1989
-
-
Garrido, P.1
Morán, J.2
Alonso, A.3
González, S.4
González, C.5
-
40
-
-
84870360401
-
Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells
-
F. O'Mahony, M. Razandi, A. Pedram, B.J. Harvey, and E.R. Levin Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells Mol Endocrinol 26 2012 2058 2070
-
(2012)
Mol Endocrinol
, vol.26
, pp. 2058-2070
-
-
O'Mahony, F.1
Razandi, M.2
Pedram, A.3
Harvey, B.J.4
Levin, E.R.5
-
41
-
-
84876666017
-
Endoplasmic reticulum stress induced by 2-deoxyglucose but not glucose starvation activates AMPK through CaMKKβ leading to autophagy
-
H. Xi, J.C. Barredo, J.R. Merchan, and T.J. Lampidis Endoplasmic reticulum stress induced by 2-deoxyglucose but not glucose starvation activates AMPK through CaMKKβ leading to autophagy Biochem Pharmacol 85 2013 1463 1477
-
(2013)
Biochem Pharmacol
, vol.85
, pp. 1463-1477
-
-
Xi, H.1
Barredo, J.C.2
Merchan, J.R.3
Lampidis, T.J.4
-
42
-
-
84861158967
-
Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death
-
G. Cheng, J. Zielonka, B.P. Dranka, D. McAllister, A.C. Mackinnon Jr., and J. Joseph et al. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death Cancer Res 72 2012 2634 2644
-
(2012)
Cancer Res
, vol.72
, pp. 2634-2644
-
-
Cheng, G.1
Zielonka, J.2
Dranka, B.P.3
McAllister, D.4
Mackinnon, Jr.A.C.5
Joseph, J.6
-
43
-
-
84862809596
-
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: From bench side to bedside
-
Y.H. Ko, H.A. Verhoeven, M.J. Lee, D.J. Corbin, T.J. Vogl, and P.L. Pedersen A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside J Bioenerg Biomembr 44 2012 163 170
-
(2012)
J Bioenerg Biomembr
, vol.44
, pp. 163-170
-
-
Ko, Y.H.1
Verhoeven, H.A.2
Lee, M.J.3
Corbin, D.J.4
Vogl, T.J.5
Pedersen, P.L.6
-
44
-
-
84858749705
-
3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects
-
S.M. El Sayed, R.M. El-Magd, Y. Shishido, S.P. Chung, T.H. Diem, and T. Sakai et al. 3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects J Bioenerg Biomembr 44 2012 61 79
-
(2012)
J Bioenerg Biomembr
, vol.44
, pp. 61-79
-
-
El Sayed, S.M.1
El-Magd, R.M.2
Shishido, Y.3
Chung, S.P.4
Diem, T.H.5
Sakai, T.6
-
45
-
-
0029120741
-
Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations
-
H. Ozcelik, S. Mousses, and I.L. Andrulis Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations Clin Cancer Res 1 1995 907 912
-
(1995)
Clin Cancer Res
, vol.1
, pp. 907-912
-
-
Ozcelik, H.1
Mousses, S.2
Andrulis, I.L.3
-
46
-
-
0035879885
-
Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas
-
I.R. Bukholm, G. Bukholm, and J.M. Nesland Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas Int J Cancer 93 2001 283 287
-
(2001)
Int J Cancer
, vol.93
, pp. 283-287
-
-
Bukholm, I.R.1
Bukholm, G.2
Nesland, J.M.3
-
47
-
-
84872032559
-
Bcl-2 and Bcl-xL suppress glucose signaling in pancreatic β-cells
-
D.S. Luciani, S.A. White, S.B. Widenmaier, V.V. Saran, F. Taghizadeh, and X. Hu et al. Bcl-2 and Bcl-xL suppress glucose signaling in pancreatic β-cells Diabetes 62 2013 170 182
-
(2013)
Diabetes
, vol.62
, pp. 170-182
-
-
Luciani, D.S.1
White, S.A.2
Widenmaier, S.B.3
Saran, V.V.4
Taghizadeh, F.5
Hu, X.6
-
48
-
-
80053404569
-
Metabolic utilization of exogenous pyruvate by mutant p53 (R175H) human melanoma cells promotes survival under glucose depletion
-
V.A. Chavez-Perez, M. Strasberg-Rieber, and M. Rieber Metabolic utilization of exogenous pyruvate by mutant p53 (R175H) human melanoma cells promotes survival under glucose depletion Cancer Biol Ther. 12 2011 647 656
-
(2011)
Cancer Biol Ther.
, vol.12
, pp. 647-656
-
-
Chavez-Perez, V.A.1
Strasberg-Rieber, M.2
Rieber, M.3
-
49
-
-
84875923648
-
Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase
-
W.L. Yeh, K. Shioda, K.R. Coser, D. Rivizzigno, K.R. McSweeney, and T. Shioda Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase PLoS One 8 2013 e60889
-
(2013)
PLoS One
, vol.8
, pp. 60889
-
-
Yeh, W.L.1
Shioda, K.2
Coser, K.R.3
Rivizzigno, D.4
McSweeney, K.R.5
Shioda, T.6
-
50
-
-
3042699999
-
Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors
-
J.V. Thottassery, Y. Sun, L. Westbrook, S.S. Rentz, M. Manuvakhova, and Z. Qu et al. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors Cancer Res 64 2004 4637 4647
-
(2004)
Cancer Res
, vol.64
, pp. 4637-4647
-
-
Thottassery, J.V.1
Sun, Y.2
Westbrook, L.3
Rentz, S.S.4
Manuvakhova, M.5
Qu, Z.6
-
51
-
-
79959691176
-
Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth
-
R.S. Tolhurst, R.S. Thomas, F.J. Kyle, H. Patel, M. Periyasamy, and A. Photiou et al. Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth Breast Cancer Res Treat 128 2011 357 368
-
(2011)
Breast Cancer Res Treat
, vol.128
, pp. 357-368
-
-
Tolhurst, R.S.1
Thomas, R.S.2
Kyle, F.J.3
Patel, H.4
Periyasamy, M.5
Photiou, A.6
-
52
-
-
58249084142
-
Phosphorylated ERα HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer
-
D. Generali, F.M. Buffa, A. Berruti, M.P. Brizzi, L. Campo, and S. Bonardi et al. Phosphorylated ERα HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer J Clin Oncol 27 2009 227 234
-
(2009)
J Clin Oncol
, vol.27
, pp. 227-234
-
-
Generali, D.1
Buffa, F.M.2
Berruti, A.3
Brizzi, M.P.4
Campo, L.5
Bonardi, S.6
-
53
-
-
79954612499
-
Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers
-
C. Coutant, R. Rouzier, Y. Qi, J. Lehmann-Che, G. Bianchini, and T. Iwamoto et al. Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers Clin Cancer Res 17 2011 2591 2601
-
(2011)
Clin Cancer Res
, vol.17
, pp. 2591-2601
-
-
Coutant, C.1
Rouzier, R.2
Qi, Y.3
Lehmann-Che, J.4
Bianchini, G.5
Iwamoto, T.6
-
54
-
-
84869083240
-
Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway
-
H. Joshi, G. Bhanot, A.L. Børresen-Dale, and V. Kristensen Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway Br J Cancer 107 2012 1722 1728
-
(2012)
Br J Cancer
, vol.107
, pp. 1722-1728
-
-
Joshi, H.1
Bhanot, G.2
Børresen-Dale, A.L.3
Kristensen, V.4
|